| Drug Type Synthetic peptide | 
| Synonyms LK-409, LK409 | 
| Target | 
| Action stimulants | 
| Mechanism CAMP stimulants(Cathelicidin antimicrobial peptide stimulants) | 
| Therapeutic Areas | 
| Active Indication- | 
| Inactive Indication | 
| Originator Organization | 
| Active Organization- | 
| Inactive Organization | 
| License Organization- | 
| Drug Highest PhaseDiscontinuedPreclinical | 
| First Approval Date- | 
| Regulation- | 
| Molecular FormulaC16H27N3O6 | 
| InChIKeyYRUZBSMLFFKORY-NWDGAFQWSA-N | 
| CAS Registry142489-43-8 | 
| Indication | Highest Phase | Country/Location | Organization | Date | 
|---|---|---|---|---|
| Immunologic Deficiency Syndromes | Preclinical | United States  | - | - | 
| Immunologic Deficiency Syndromes | Preclinical | Japan  | - | - | 
| Immunologic Deficiency Syndromes | Preclinical | Slovenia  | - | |
| Immunologic Deficiency Syndromes | Preclinical | Slovenia  | - | |
| Neoplasms | Preclinical | Slovenia  | - | |
| Neoplasms | Preclinical | Slovenia  | - | 






